Literature DB >> 27245715

The role of appropriate diagnostic testing in acute respiratory tract infections: An antibiotic stewardship strategy to minimise diagnostic uncertainty in primary care.

Adrian John Brink1, Johan Van Wyk, V M Moodley, Craig Corcoran, Pieter Ekermans, Louise Nutt, Tom Boyles, Olga Perovic, Charles Feldman, Guy Richards, Marc Mendelson.   

Abstract

Antibiotic resistance has increased worldwide to the extent that it is now regarded as a global public health crisis. Interventions to reduce excessive antibiotic prescribing to patients can reduce resistance and improve microbiological and clinical outcomes. Therefore, although improving outpatient antibiotic use is crucial, few data are provided on the key interventional components and the effectiveness of antibiotic stewardship in the primary care setting, in South Africa. The reasons driving the excessive prescription of antibiotics in the community are multifactorial but, perhaps most importantly, the overlapping clinical features of viral and bacterial infections dramatically reduce the ability of GPs to distinguish which patients would benefit from an antibiotic or not. As a consequence, the need for tools to reduce diagnostic uncertainty is critical. In this regard, besides clinical algorithms, a consensus of collaborators in European and UK consortia recently provided guidance for the use of C-reactive protein point-of-care testing in outpatients presenting with acute respiratory tract infections (ARTIs) and/or acute cough, if it is not clear after proper clinical assessment whether antibiotics should be prescribed or not. A targeted application of stewardship principles, including diagnostic stewardship as described in this review, to the ambulatory setting has the potential to affect the most common indications for systemic antibiotic use, in that the majority (80%) of antibiotic use occurs in the community, with ARTIs the most common indication.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27245715     DOI: 10.7196/SAMJ.2016.v106i6.10857

Source DB:  PubMed          Journal:  S Afr Med J


  7 in total

Review 1.  South African guideline for the management of community-acquired pneumonia in adults.

Authors:  Tom H Boyles; Adrian Brink; Greg L Calligaro; Cheryl Cohen; Keertan Dheda; Gary Maartens; Guy A Richards; Richard van Zyl Smit; Clifford Smith; Sean Wasserman; Andrew C Whitelaw; Charles Feldman
Journal:  J Thorac Dis       Date:  2017-06       Impact factor: 2.895

2.  Integrated Stewardship Model Comprising Antimicrobial, Infection Prevention, and Diagnostic Stewardship (AID Stewardship).

Authors:  J H Dik; R Poelman; A W Friedrich; H G M Niesters; J W A Rossen; B Sinha
Journal:  J Clin Microbiol       Date:  2017-11       Impact factor: 5.948

Review 3.  Nurse-led versus doctor-led care for bronchiectasis.

Authors:  Kathryn Lawton; Karen Royals; Kristin V Carson-Chahhoud; Fiona Campbell; Brian J Smith
Journal:  Cochrane Database Syst Rev       Date:  2018-06-20

4.  Quality Attributes and In Vitro Bioequivalence of Different Brands of Amoxicillin Trihydrate Tablets.

Authors:  Moawia M Al-Tabakha; Khairi M S Fahelelbom; Dana Emad Eddin Obaid; Sadik Sayed
Journal:  Pharmaceutics       Date:  2017-05-20       Impact factor: 6.321

Review 5.  Antimicrobial Resistance in Escherichia coli Strains Isolated from Humans and Pet Animals.

Authors:  Nikola Puvača; Rosa de Llanos Frutos
Journal:  Antibiotics (Basel)       Date:  2021-01-13

6.  Prevalence and antimicrobial susceptibility level of typhoid fever in Ethiopia: A systematic review and meta-analysis.

Authors:  Melese Yeshambaw Teferi; Ziad El-Khatib; Endawoke Amsalu Alemayehu; Hawult Taye Adane; Azeb Tarekegn Andualem; Yonas Abebe Hailesilassie; Abraham Sahilemichael Kebede; Benedict Oppong Asamoah; Minyahil Tadesse Boltena; Mulatu Biru Shargie
Journal:  Prev Med Rep       Date:  2021-12-13

Review 7.  Appropriate antibiotic management of bacterial lower respiratory tract infections.

Authors:  Charles Feldman; Guy Richards
Journal:  F1000Res       Date:  2018-07-23
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.